−0.52 EUR
−6.52 M EUR
22.00 EUR
11.57 M
About MOLECURE
Sector
CEO
Marcin Jan Szumowski
Headquarters
Warsaw
Website
Founded
2012
ISIN
PLONCTH00011
FIGI
BBG00ZHRHVD3
Molecure SA engages in the discovery and development of small molecules for the treatment of unmet medical needs. It offers a platform of distinct small molecule programs targeting chitinases and chitinase-like-proteins, with potential utility in diverse inflammatory and fibrotic diseases. The company was founded by Stanislaw Wieslaw Pikul and Adam Golebiowski on March 12, 2012 and is headquartered in Warsaw, Poland.
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 1B1 is 2.22 EUR — it has decreased by −3.48% in the past 24 hours. Watch MOLECURE SPOLKA AKCYJNA stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on GETTEX exchange MOLECURE SPOLKA AKCYJNA stocks are traded under the ticker 1B1.
1B1 stock has risen by 2.07% compared to the previous week, the month change is a −1.33% fall, over the last year MOLECURE SPOLKA AKCYJNA has showed a −51.53% decrease.
We've gathered analysts' opinions on MOLECURE SPOLKA AKCYJNA future price: according to them, 1B1 price has a max estimate of 4.64 EUR and a min estimate of 4.08 EUR. Watch 1B1 chart and read a more detailed MOLECURE SPOLKA AKCYJNA stock forecast: see what analysts think of MOLECURE SPOLKA AKCYJNA and suggest that you do with its stocks.
1B1 stock is 7.98% volatile and has beta coefficient of 0.60. Track MOLECURE SPOLKA AKCYJNA stock price on the chart and check out the list of the most volatile stocks — is MOLECURE SPOLKA AKCYJNA there?
Today MOLECURE SPOLKA AKCYJNA has the market capitalization of 37.15 M, it has decreased by −4.29% over the last week.
Yes, you can track MOLECURE SPOLKA AKCYJNA financials in yearly and quarterly reports right on TradingView.
1B1 net income for the last quarter is −1.46 M EUR, while the quarter before that showed −1.79 M EUR of net income which accounts for 18.36% change. Track more MOLECURE SPOLKA AKCYJNA financial stats to get the full picture.
No, 1B1 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 25, 2024, the company has 111.00 employees. See our rating of the largest employees — is MOLECURE SPOLKA AKCYJNA on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. MOLECURE SPOLKA AKCYJNA EBITDA is −8.54 M EUR, and current EBITDA margin is −32.13 M%. See more stats in MOLECURE SPOLKA AKCYJNA financial statements.
Like other stocks, 1B1 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade MOLECURE SPOLKA AKCYJNA stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So MOLECURE SPOLKA AKCYJNA technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating MOLECURE SPOLKA AKCYJNA stock shows the sell signal. See more of MOLECURE SPOLKA AKCYJNA technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.